Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Assets (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Assets for 4 consecutive years, with 0.21% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 14.0% to 0.21% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.21%, a 14.0% increase, with the full-year FY2025 number at 0.2%, changed 0.0% from a year prior.
  • Return on Assets was 0.21% for Q4 2025 at Day One Biopharmaceuticals, up from 0.29% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.18% in Q2 2025 to a low of 0.76% in Q2 2024.
  • A 4-year average of 0.4% and a median of 0.39% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: tumbled -33bps in 2024, then surged 58bps in 2025.
  • Day One Biopharmaceuticals' Return on Assets stood at 0.39% in 2022, then decreased by -23bps to 0.48% in 2023, then increased by 28bps to 0.35% in 2024, then surged by 39bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Return on Assets are 0.21% (Q4 2025), 0.29% (Q3 2025), and 0.18% (Q2 2025).